小组心理护理对躯体形式障碍患者述情障碍的影响

目的:研究小组心理护理对躯体形式障碍患者述情障碍的疗效. 方法:将符合入组标准的躯体形式障碍患者63例随机分为试验组32例和对照组31例,分别对两组患者进行常规药物治疗和护理,且对试验组进行小组心理护理.对完成研究的试验组30例患者和对照组30例患者进行多伦多述情障碍量表(TAS)和临床疗效总评量表(CGI)的测试. 结果:①重复测量的方差分析发现干预因素对TAS因子Ⅰ、因子Ⅱ和因子Ⅳ存在主效应(F=4.291 ～5.844,P＜0.05)；时间因素对TAS因子Ⅰ、因子Ⅱ、因子Ⅲ和因子Ⅳ均存在主效应(F=31.283～99.974,P＜0.01)；干预因素和时间因素对TAS因子Ⅰ、因子Ⅱ和因子Ⅳ存在交互作用(F =7.815～12.541,P＜0.01).②逐步回归分析显示干预前TAS各因子分数和小组心理护理对TAS因子Ⅰ、因子Ⅱ、因子Ⅳ减少值具有显著的预测作用(Beta值=4.572～13.199,P＜0.01).③试验组疗效(76.7％)优于对照组(50％)；多因素Logistic回归分析显示,对躯体形式障碍患者临床疗效影响从大到小的因素分别是:小组心理护理、TAS因子Ⅰ、TAS因子Ⅱ和TAS因子Ⅳ(OR =9.721～1.237). 结论:小组心理护理能够改善躯体形式障碍患者的述情障碍和临床疗效.

The effect of group psychological nursing on alexithymia of patients with somatoform disorder

Objective:To study the effect of group psychological nursing on alexithymia of patients with somatoform disorder.Method:60 somatoform disorder patients were divided into two groups randomly:the treatment group (30 patients) and the control group (30 patients).In two groups,every patient was treated with regular medicine and nursing separately while group psychological nursing was carried on in the treatment group.Toronto alexithymia scale (TAS) and clinical global impression (CGI) were measured in two groups after treatment.Results:①The repeated measures variance analysis indicated that treatment factor showed the main effect on factorⅠ,factor Ⅱ,factor Ⅳ of TAS (F=4.291～5.844,all P<0.05).The time factor showed the main effect on various factors of TAS(F=31.283～99.974,all P<0.01).Also the treatment factor and the time factor had interaction effect to factor Ⅰ,factor Ⅱ,factor Ⅳ of TAS (F=7.815～12.541,all P<0.01).②Stepwise regression analysis showed that group psychological nursing,each factor score of TAS before treatment had a remarkable predictive effect to decreased score of factor Ⅰ,factor Ⅱ,factor Ⅳ of TAS (Beta=4.572～13.199,all P<0.01).③Logistic regression analysis showed that the risk factors to treatment effect were group psychological nursing,and factor Ⅰ,factor Ⅱ,factor Ⅳ of TAS.Conclusion:The group psychological nursing can improve the alexithymia and the treatment effect in patients with somatoform disorder.